"The Booth Gardner Parkinson's Care Center at EvergreenHealth improves the quality of life for patients and families living with Parkinson's disease and related conditions. The care at our Parkinson's center is both comprehensive and compassionate."

During the past decade, Booth Gardner Parkinson's Care Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 10 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Booth Gardner Parkinson's Care Center" #1 sponsor was "Impax Laboratories, LLC" with 3 trials, followed by "Enterin Inc." with 2 trials sponsored, "Intec Pharma Ltd." with 2 trials sponsored, "Jazz Pharmaceuticals" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Booth Gardner Parkinson's Care Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "The Parkinson Study Group" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Booth Gardner Parkinson's Care Center" are "Parkinson Disease" (8 trials), "Parkinson's Disease" (3 trials), "Constipation" (2 trials), "Huntington Disease" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Booth Gardner Parkinson's Care Center" in a lesser frequency.

Most popular intervention types in "Booth Gardner Parkinson's Care Center" are "Drug" (22 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Active Investigational Treatment ENT-01" (2 trials), "1 mg QD to 15 mg QD PF-06649751" (1 trials) and "1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Booth Gardner Parkinson's Care Center" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Booth Gardner Parkinson's Care Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Booth Gardner Parkinson's Care Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Booth Gardner Parkinson's Care Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".